Furthermore, methylation of the cyclin inhibitors p16INK4a and p15INK4b is an event found in early stages of HCC as well as in cirrhotic patients, although at a smaller rate, suggesting that these epigenetic modifications play a role in certain aspects of hepatocarcinogenesis [37,38,39]. This evidence concerns the gene CDKN2B and hepatocellular carcinoma.